Skip to main content
. 2026 Feb 14;18(4):626. doi: 10.3390/cancers18040626
SD Stable Disease
BID Twice a day
ORR Overall Response Rate
PR Partial Response
CR Complete Response
DLT Drug Limiting Toxicity